Home

Letters, Testimony & Comments

BIO Written Testimony: Spurring Job Growth Through Capital Formation While Protecting Investors
December 1, 2011
On December 1, BIO submitted written testimony to the Senate Committee on Banking, Housing, and Urban Affairs on the importance of...
December 1 2011
Testimony in Support of USDA Research
July 28, 2011
The Biotechnology Industry Organization (BIO) is the world's largest biotechnology organization, providing advocacy, business...
July 28 2011
President's Council of Advisors on Science and Technology (PCAST)
January 11, 2011
January 7, 2011 President's Council of Advisors on Science and Technology (PCAST) Public Oral Comments Ladies and Gentlemen:...
January 11 2011
BIO Comments, Draft National Institutes of Health Guidelines for Human Stem Cell Research
May 27, 2009
Re: Draft National Institutes of Health Guidelines for Human Stem Cell Research (FR Doc. E9-9313) Dear Sir/Madam: The Biotechnology...
May 27 2009
The Stem Cell Research Enhancement Act
June 6, 2007
BIO Letter to Speaker Pelosi regard BIO's support for S. 5
June 6 2007
BIO Support for S.5, the Stem Cell Research Enhancement Act
April 10, 2007
Letter to Senate Majority Leader Henry Reid
April 10 2007
BIO Comments, Proposed California IP regulation for Non-profit Organizations
June 16, 2006
June 16 2006
The Role of Universities in Biotech Product Development and Capacity Building
November 20, 2004
Janna Tom, Assistant Director, Office of Technology Transfer, University of California; Vice President for Public Policy, Association of...
November 20 2004
BIO's Comments to FDA's Proposed Rule on Institutional Review Board (IRB) Registration Requirements
September 27, 2004
Dear Sir/Madam: The following comments are provided by the Biotechnology Industry Organization (BIO). BIO represents more than 1,000...
September 27 2004
BIO Position on Stem Cell Research
January 17, 2001
President-Elect George W. Bush Bush-Cheney Transition Headquarters 1800 G Street, N.W. Washington, DC 20270 Dear President-Elect...
January 17 2001
BIO Response to NBAC on Stem Cell Research
March 22, 1999
Harold Shapiro, Ph.D. Chairman c/o E. Randolph Hull National Bioethics Advisory Commission 6100 Executive Blvd., Suite 5B01...
March 22 1999
BIO Statement Regarding Commercial Development of Pluripotent Stem Cells
January 12, 1999
EXECUTIVE SUMMARY Pluripotent stem cells research provides the hope of a new generation of therapeutics. Using cell transplants...
January 12 1999
Animal Biotechnology: All About Animal Cloning
Cloning is the most recent evolution of selective assisted breeding in animal husbandry. Cloning animals is a reliable way of reproducing...
Presentation: "Global Health Challenges: How Industry is Addressing Global Health", presented at the University of Virginia in June 2008
Every Year... -of the 57 million people who die, 10.5 million are children under 5 years and 1.5 million are children between the ages...

Letters, Testimony & Comments

BIO Written Testimony: Spurring Job Growth Through Capital Formation While Protecting Investors
December 1 2011
On December 1, BIO submitted written testimony to the Senate Committee on Banking, Housing, and Urban Affairs on the importance of...
Testimony in Support of USDA Research
July 28 2011
The Biotechnology Industry Organization (BIO) is the world's largest biotechnology organization, providing advocacy, business...
President's Council of Advisors on Science and Technology (PCAST)
January 11 2011
January 7, 2011 President's Council of Advisors on Science and Technology (PCAST) Public Oral Comments Ladies and Gentlemen:...
BIO Comments, Draft National Institutes of Health Guidelines for Human Stem Cell Research
May 27 2009
Re: Draft National Institutes of Health Guidelines for Human Stem Cell Research (FR Doc. E9-9313) Dear Sir/Madam: The Biotechnology...
The Stem Cell Research Enhancement Act
June 6 2007
BIO Letter to Speaker Pelosi regard BIO's support for S. 5
More Letters, Testimony & Comments →

Press Releases

Indian Supreme Court Ruling Negatively Affects Innovation
April 8 2013
Washington, D.C. (April 8, 2013) –  The Biotechnology Industry Organization (BIO) issued the following...
BIO Praises Rep. Michael Fitzpatrick on Introduction of Fostering Innovation Act
July 20 2012
Washington, D.C. (July 20, 2012) – Today, Representative Michael Fitzpatrick (R-PA) introduced H.R. 6161, the...
BIO Praises Senate Passage of the Jumpstart Our Business Startups (JOBS) Act
March 22 2012
  Washington, DC (March 22, 2012) – The Biotechnology Industry Organization (BIO) applauds the Senate...
BIO Comments on New Initiatives to Grow Nation’s Bioeconomy
September 16 2011
Washington, D.C. (September 16, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim...
Synthetic Biology’s Potential for Commercial Innovation Should Be Supported, BIO Argues
September 1 2011
WASHINGTON, D.C.(Sept. 1, 2011) – Research and development in synthetic biology is an evolution of...
More Press Releases →